Açaí may modulate the progress of breast cancer by decreasing the presence of the activated macrophages in the tumors, which leads to reductions of VEGF, VEGFR-2, COX-2, PGE2 and IL-10 levels, thereby supporting the use of açaí for an adjuvant treatment together with chemotherapy drugs. This evidence concerns the gene KDR and breast carcinoma.